Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure (Q35723859)
Jump to navigation
Jump to search
scientific article published on 19 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure |
scientific article published on 19 May 2015 |
Statements
1 reference
Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure (English)
1 reference
Hikmet Nural-Guvener
1 reference
Liudmila Zakharova
1 reference
Lorraine Feehery
1 reference
Snjezana Sljukic
1 reference
Mohamed Gaballa
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference